Sopharma AD - Asset Resilience Ratio

Latest as of March 2025: 0.00%

Sopharma AD (SPH) has an Asset Resilience Ratio of 0.00% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Sopharma AD strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

zł80.00K

≈ $22.02K USD Cash + Short-term Investments

Total Assets

zł1.94 Billion

≈ $534.73 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2023)

This chart shows how Sopharma AD's Asset Resilience Ratio has changed over time. See Sopharma AD (SPH) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sopharma AD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sopharma AD stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	zł0.00	0%
Short-term Investments	zł80.00K	0.0%
Total Liquid Assets	zł80.00K	0.00%

Asset Resilience Insights

Limited Liquidity: Sopharma AD maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sopharma AD Industry Peers by Asset Resilience Ratio

Compare Sopharma AD's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Jointown Pharmaceutical Group Co Ltd SHG:600998	Medical Distribution	0.08%
Arjo AB (publ) ST:ARJO-B	Medical Distribution	0.18%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Mayne Pharma Group Ltd AU:MYX	Medical Distribution	4.00%
Cyclopharm Ltd AU:CYC	Medical Distribution	1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%

Annual Asset Resilience Ratio for Sopharma AD (2013–2023)

The table below shows the annual Asset Resilience Ratio data for Sopharma AD.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.02%	zł-271.00K ≈ $-74.58K	zł1.51 Billion ≈ $416.72 Million	-0.01pp
2022-12-31	-0.01%	zł-140.00K ≈ $-38.53K	zł1.26 Billion ≈ $345.61 Million	-0.05pp
2016-12-31	0.04%	zł316.00K ≈ $86.97K	zł859.22 Million ≈ $236.47 Million	0.00pp
2015-12-31	0.04%	zł314.00K ≈ $86.42K	zł835.63 Million ≈ $229.98 Million	+0.12pp
2013-12-31	-0.08%	zł-638.00K ≈ $-175.59K	zł782.79 Million ≈ $215.43 Million	--

pp = percentage points

About Sopharma AD

WAR:SPH Poland Medical Distribution

Market Cap

$1.14 Billion

zł4.14 Billion PLN

Market Cap Rank

#8518 Global

#42 in Poland

Share Price

zł7.98

Change (1 day)

-0.50%

52-Week Range

zł7.12 - zł16.00

All Time High

zł17.83